On October 24-26, 2017, CPhI Worldwide 2017 (CPhI Worldwide 2017) was held at the Frankfurt Expo Center in Germany, and Viwit was invited to participate in this exhibition as one of the representative companies in China.

It is understood that CPhI worldwide is a well-known brand exhibition in the field of international pharmaceutical raw materials and a professional exhibition in the field of pharmaceutical raw materials and intermediates. The holding of this exhibition is a big gathering of the global pharmaceutical industry, and it serves as a vane for the development direction of the entire pharmaceutical industry.

As a medical and health enterprise integrating research and development, production, and sales based on technological innovation, Viwit has always received the attention and recognition of large domestic and foreign manufacturers and new and old customers. The exhibition lasted for three days, and a total of hundreds of customers came to the viwit booth to consult the latest technology applications and product information of the company. The exhibition materials prepared every day were always snatched out in the shortest time. With the conclusion of the exhibition, Viwit was a fruitful one. After three days, the company received a considerable number of inquiries and orders.

Group Chairman and President Wei Yanjun came to the exhibition site and met with more than 200 customers and manufacturers. President Wei Yanjun expressed gratitude to many old customers on behalf of Viwit, and promised to maintain a good partnership. At the same time, he welcomed many new customers, and demonstrated the strength and value of Viwit through introduction and visit.

Through this exhibition, Viwit's global business team increased communication and exchanges with customers at home and abroad, increased friendship and feelings, and laid a deep foundation for the next long-term cooperation and the expansion of the global market. Viwit will live up to expectations. It will practice the "customer first" concept with higher quality and better service to create more value and contribute its own strength to the development of the global pharmaceutical industry.